- N/T
Tharimmune
Market data is not available yet
At the moment, the Project may be in preliminary stages (Seed, Private Sale, Presale, ICO). The information provided below may be inaccurate (Beta) and being updated.
Investors
X Followers
X Performance
--Rank by X N/A- 0
- 100
- 500
- 1000
- 1500
Fundraising
See More--USD ROI
--BTC ROI
--ETH ROI
- ICO Price
- --
- Funds Raised
- $540.00 M
- Tokens Sold
- --
About Tharimmune
Tharimmune is a biotechnology company developing new drugs for rare immune and inflammatory diseases, as well as cancer. It uses cutting-edge methods, such as multi-target antibodies, and targets areas of medicine where effective solutions are currently scarce.
Official Links
Fundraising
See More--USD ROI
--BTC ROI
--ETH ROI
- ICO Price
- --
- Funds Raised
- $540.00 M
- Tokens Sold
- --